Decision Diagnostics Corp. (OTCBB: DECN) Lead Product; GenStrip ® Blood Glucose Test Strips
Frequent and accurate testing of blood glucose is essential to the treatment of diabetes. Unfortunately, high costs of testing supplies puts regular monitoring out of reach for many diabetics. GenStrip® Blood Glucose Test Strips make blood glucose testing fast, easy, convenient, and more affordable for anyone living with diabetes. This new diagnostic product is compatible with a family of existing meters provided by the platform manufacturer, but priced significantly (50%) lower. GenStrip is in the final stages of FDA approval.
In March 2012 and then again September 2012 representatives of the company and Shasta Technologies LLC met face-to-face with the FDA to ask questions and respond to FDA comments and to present its case in an effort to complete the FDA review process. Subsequently Shasta Technologies LLC and the company have received and responded to a short series of follow up questions and comments by FDA.
Decision Diagnostics Company websitehttp://www.decisiondiagnostics.com/
DECN SEC file
More info on DECN at Investorideas.com http://www.investorideas.com/ CO/DECN/
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts at Investorideas.com
Disclaimer/ Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Disclosure: Investorideas.com has been compensated one hundred fifty thousand shares for news and content publication and distribution for 45 days
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com